Quality, Standards & Compliance
|2 min read
Five Hard-Hitting Quotes from the 2026 Lab Manager Leadership Summit
Words of Curtiss McNair, Jr., Stacey Metzler, and others can guide clinical lab managers|3 min read
AI Is Entering the Lab. Are Lab Managers Ready?
The lab is adopting AI faster than it can be validated. To get it right, managers must apply the same scrutiny they would to any other tool|3 min read
Sapio Sciences Integrates Claude AI, Aiming to Simplify Lab Data Access
Integration of Anthropic’s Claude AI assistant with Sapio Elain aims to unify data retrieval, analysis, and workflow automation across ELN and LIMS from a single conversational interface|3 min read
PFAS Exposure Is Accelerating Aging: What New Research Shows About ‘Forever Chemicals’
New research found links between PFAS exposure and advanced mortality- and metabolism-related aging, with effects dependent on sex and age|2 min read
The US Is Driving a Public Health Emergency of International Concern
Experts call for global collaboration to mitigate the harms of US policy changes|1 min read
Clinical Water Decisions Start Where Purity Specs End
A seven-criteria evaluation framework for clinical labs making a capital water system purchaseSponsored by
|1 min read
DEA Places Bromazolam in Schedule I, Signaling New Lab Compliance Requirements
Forensic and toxicology labs handling or testing this designer benzodiazepine must follow updated Schedule I regulations|2 min read
Amplified Sciences Achieves CAP Accreditation for Cutting-Edge Diagnostic Lab
Gold standard milestone clears the path for national expansion of PanCystPro™ assay|1 min read
Standardizing Oncology Assays: A Guide to Cell Line-Derived Reference Materials
Identify the limitations of patient tissue controls in genetic testing and examine the verification data supporting cell line-derived standardsSponsored by
|1 min read
Move Past the Limitations of Synthetic Reference Standards in Cancer Research
A review of cell line-derived reference standards for the investigation and molecular profiling of myeloid malignanciesSponsored by
|5 min read
Medicare Is Experimenting with Having AI Review Claims—a Cost-Saving Measure That Could Risk Denying Needed Care
A new pilot brings some automated treatment decisions from Medicare Advantage to traditional Medicare|3 min read















